The Neurology segment focuses on developing and commercializing treatments for neurological disorders, including Parkinson's disease and multiple sclerosis. Key products include Osmolex ER for Parkinson's disease and Arbaclofen ER, which is in Phase III clinical trials for multiple sclerosis spasticity. Research and development efforts are directed towards understanding the underlying mechanisms of these conditions and identifying novel therapeutic targets. The segment aims to improve the quality of life for patients with neurological disorders by providing effective and convenient treatment options. Future opportunities include expanding the product pipeline with innovative therapies and exploring new indications for existing drugs.

The Ophthalmology segment is dedicated to developing and commercializing treatments for eye-related conditions, with a focus on ocular aesthetics and vision correction. A key product in this segment is Upneeq, an oxymetazoline hydrochloride ophthalmic solution for the treatment of blepharoptosis (droopy eyelid). The segment's research and development activities are centered on identifying innovative solutions for common eye conditions and improving patient outcomes. Future opportunities include expanding the product portfolio with new ophthalmic solutions and exploring strategic partnerships to enhance market reach and penetration. The segment aims to provide effective and convenient treatment options for patients with various eye conditions, improving their overall quality of life.

The Women's Health segment focuses on providing pharmaceutical products and dietary supplements tailored to the specific needs of women. Key products include Divigel for menopause and OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods. Research and development efforts are directed towards identifying innovative solutions for women's health issues and improving patient outcomes. Future opportunities include expanding the product portfolio with new women's health products and exploring strategic partnerships to enhance market reach and penetration. The segment aims to provide effective and convenient treatment options for women at various stages of life, improving their overall well-being.